BCL2 and colorectal carcinoma: Mitochondrial-targeted delivery of curcumin simultaneously modulates multiple pathways, including inhibiting survivin expression, increasing p53 accumulation, elevating the Bax/Bcl-2 ratio, and activating caspase-9, resulting in highly effective killing of human CRC LoVo cells.89